Levo Therapeutics LV-101 Prader-Willi syndrome

Levo starts enrolment in Phase III trial of intranasal carbetocin

Levo Therapeutics has started patient enrolment in its Phase III CARE-PWS clinical study to evaluate the effectiveness of intranasal carbetocin…